Eidos Therapeutics, Inc. (EIDX) has 72 open-market insider trades by 11 insiders since 2018. The most active filer is Jonathan C. Fox.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Neil Kumar | CEO | — | 4 | $171.2M | 2019-07-03 |
| Ali J. Satvat | Dir10% Owner | — | 4 | $171.2M | 2019-07-03 |
| Eric Aguiar | Dir10% Owner | — | 2 | $110.0M | 2019-07-03 |
| BridgeBio Pharma, Inc. | 10% Owner | — | 2 | $55.0M | 2019-07-03 |
| Rajeev M. Shah | Dir | — | 1 | $18.0M | 2018-06-22 |
| BridgeBio Pharma LLC | 10% Owner | — | 3 | $17.1M | 2018-12-10 |
| Cameron Turtle | — | — | 12 | $12.1M | 2021-01-26 |
| Christine Siu | CFOSecretary | — | 9 | $8.5M | 2019-12-09 |
| Jonathan C. Fox | — | — | 21 | $7.7M | 2021-01-26 |
| Uma Sinha | CSO | — | 8 | $4.3M | 2021-01-26 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Uma Sinha | CSO | Sell | $2.2M | 2021-01-13 |
| Franco Valle | President & VP | Sell | $627K | 2021-01-11 |
| Cameron Turtle | — | Sell | $5.0M | 2020-12-15 |
| Uma Sinha | CSO | Sell | $854K | 2020-12-02 |
| Cameron Turtle | — | Sell | $2.0M | 2020-11-11 |
| Franco Valle | President & VP | Sell | $243K | 2020-11-09 |
Companies that share insiders with EIDX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Cameron Turtle | — | Sell | $1.8M | 2020-11-02 |
| Uma Sinha | CSO | Sell | $456K | 2020-10-29 |
| Franco Valle | President & VP | Sell | $1.6M | 2020-10-07 |
| Uma Sinha | CSO | Sell | $515K | 2020-09-30 |
| Jonathan C. Fox | — | Sell | $579K | 2020-09-17 |
| Jonathan C. Fox | — | Sell | $369K | 2020-09-14 |
| Cameron Turtle | — | Sell | $118K | 2020-09-10 |
| Cameron Turtle | — | Sell | $509K | 2020-08-03 |
| Jonathan C. Fox | — | Sell | $250K | 2020-07-07 |